Search results
Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation
Medical Xpress· 6 hours agoCAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors...
CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors...